Posted by: SomaNews on: 23 Sep, 2009
Blood Tests May Detect Colon Cancer
Two new blood tests may help to make the diagnosis of colon and other gastrointestinal cancers simpler, cheaper, and less unpleasant.
Posted by: SomaNews on: 23 Sep, 2009
Hand Hygiene Habits Improve
Americans get a B- for their hand hygiene habits, up from a C- grade in 2008, a new survey shows.
Posted by: SomaNews on: 23 Sep, 2009
Surgery Improves Late-Stage Breast Cancer
Women whose breast cancer is diagnosed late, when it has already spread to other parts of the body, live about a year and a half longer if their breast tumor is surgically removed, researchers report.
Posted by: SomaNews on: 23 Sep, 2009
FDA Bans Flavored Cigarettes
Because they “lure kids into addiction,” the FDA has banned cigarettes with herb, spice, candy, cola, and fruit flavors. Menthol cigarettes are exempt from the ban.
Posted by: SomaNews on: 23 Sep, 2009
Med Students Put Unprofessional Info Online
It is not uncommon for medical students to post unprofessional and even illegal information on social networking sites like Facebook and media-sharing sites like YouTube, a survey of medical schools shows.
Posted by: SomaNews on: 23 Sep, 2009
Gene Therapy May Cure Color Blindness
New research suggests that gene therapy could one day give color-blind adults the ability to see in full color.
Posted by: SomaNews on: 23 Sep, 2009
Fertility Drug May Be New Hot Flash Treatment
Women suffering severe postmenopausal hot flashes get relief from daily injections of the fertility drug Cetrotide, a small Dutch study shows.
Posted by: SomaNews on: 23 Sep, 2009
Vaccine Aims to Block Bladder Infections
In early studies in mice, a nasal vaccine was found to prevent bladder and other urinary tract infections.
Posted by: SomaNews on: 23 Sep, 2009
Helsinn’s Palonosetron Effective In Preventing Emesis, Nausea Induced by High Dose Chemotherapy
Palonosetron, a second generation 5-HT3 receptor antagonist, patients undergoing multiday-HDT and ASCT
Posted by: SomaNews on: 23 Sep, 2009
Genomic Confirms Consistent Distribution Of Oncotype DX
Study indicates less than 50% of early-stage breast cancer patients in Europe and the Middle East likely to benefit from chemotherapy
Recent Comments